CME Cme Group Inc

  1. Stocks
  2. Financial Services
  3. NASDAQ: CME

Price (delayed)

$200.45

Market cap

$72.11B

P/E Ratio

24.45

Dividend/share

$8.8

EPS

$8.2

Enterprise value

$186.9B

CME Group Inc. is a global markets company. It is the world's largest financial derivatives exchange, and trades in asset classes that include agricultural products, currencies, energy, interest rates, metals, ...

Highlights
The debt has declined by 18% year-on-year and by 11% since the previous quarter
The gross profit has increased by 8% YoY and by 2.4% from the previous quarter
CME's P/E is 19% below its 5-year quarterly average of 30.0 but 4.3% above its last 4 quarters average of 23.4
Sector: Financial Services
Industry: Financial Data & Stock Exchanges
Website: https://www.cmegroup.com/
Peers: MSCI ICE CBOE NDAQ

Key stats

What are the main financial stats of CME
Market
Shares outstanding
359.75M
Market cap
$72.11B
Enterprise value
$186.9B
Valuations
Price to earnings (P/E)
24.45
Price to book (P/B)
2.59
Price to sales (P/S)
13.74
EV/EBIT
46.49
EV/EBITDA
42.68
EV/Sales
35.69
Earnings
Revenue
$5.24B
EBIT
$4.02B
EBITDA
$4.38B
Free cash flow
$3.11B
Per share
EPS
$8.2
Free cash flow per share
$8.66
Book value per share
$77.33
Revenue per share
$14.59
TBVPS
$335.63
Balance sheet
Total assets
$151.3B
Total liabilities
$123.48B
Debt
$116.67B
Equity
$27.82B
Working capital
$2.48B
Liquidity
Debt to equity
4.19
Current ratio
1.02
Quick ratio
1.02
Net debt/EBITDA
26.21
Margins
EBITDA margin
83.6%
Gross margin
100%
Net margin
56.5%
Operating margin
60.3%
Efficiency
Return on assets
1.8%
Return on equity
10.7%
Return on invested capital
2.9%
Return on capital employed
10.7%
Return on sales
76.8%
Dividend
Dividend yield
4.39%
DPS
$8.8
Payout ratio
107.3%

CME stock price

How has the Cme Group stock price performed over time
Intraday
0.15%
1 week
0.31%
1 month
-1.2%
1 year
12.5%
YTD
19.2%
QTD
0.11%

Financial performance

How have Cme Group's revenue and profit performed over time
Revenue
$5.24B
Gross profit
$5.24B
Operating income
$3.16B
Net income
$2.96B
Gross margin
100%
Net margin
56.5%
The operating income is up by 11% YoY and by 2.9% QoQ
The gross profit has increased by 8% YoY and by 2.4% from the previous quarter
CME's revenue is up by 8% year-on-year and by 2.4% since the previous quarter
The net margin has declined by 6% year-on-year

Growth

What is Cme Group's growth rate over time

Valuation

What is Cme Group stock price valuation
CME P/E details
P/E
24.45
P/B
2.59
P/S
13.74
EV/EBIT
46.49
EV/EBITDA
42.68
EV/Sales
35.69
CME's P/E is 19% below its 5-year quarterly average of 30.0 but 4.3% above its last 4 quarters average of 23.4
The EPS is up by 4.1% since the previous quarter
CME's price to book (P/B) is 8% higher than its last 4 quarters average of 2.4 and 3.6% higher than its 5-year quarterly average of 2.5
CME's revenue is up by 8% year-on-year and by 2.4% since the previous quarter
The P/S is 8% higher than the last 4 quarters average of 12.7 but 4.1% lower than the 5-year quarterly average of 14.3

Efficiency

How efficient is Cme Group business performance
The ROIC has grown by 21% YoY and by 7% from the previous quarter
Cme Group's return on assets has increased by 20% YoY and by 13% QoQ
Cme Group's return on equity has increased by 4.9% QoQ
The return on sales has declined by 2.9% year-on-year

Dividends

What is CME's dividend history
Dividend details
DPS
$8.8
Dividend yield
4.39%
Payout ratio
107.3%
Recent dividends

Financial health

How did Cme Group financials performed over time
Cme Group's total assets is 23% more than its total liabilities
Cme Group's total liabilities has decreased by 17% YoY and by 11% QoQ
Cme Group's total assets has decreased by 14% YoY and by 9% from the previous quarter
The debt has declined by 18% year-on-year and by 11% since the previous quarter
The debt to equity has contracted by 17% YoY and by 13% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.